Stage IIIB Breast Cancer AJCC v7 Active Not Recruiting Phase 2 Trials for Cixutumumab (DB12250)

IndicationStatusPhase
DBCOND0092287 (Stage IIIB Breast Cancer AJCC v7)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs